From strategy to execution, we help you understand your compound’s safety profile.
- Nonclinical, non-GLP, cardiovascular function characterization
- Clinical convulsive risk nonclinical strategies
- Endocrine function evaluation
- Safety margin characterizations relative to therapeutic effects
- Receptor Occupancy assay to help guide decision making
- Regulatory consultation on nonclinical studies